ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 172

S100A8/A9 Produced during Experimental Osteoarthritis Induces a Systemic Decrease in BM Monocytes and Increases Ly6C High Monocytes Locally in the Joint

Niels Cremers, Edwin Geven, Arjen Blom, Annet Sloetjes, Irene Di Ceglie, Stephanie van Dalen, Giuliana Ascone, Martijn van den Bosch and Peter van Lent, Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: innate immunity, macrophages, monocytes and osteoarthritis, Systemic Inflammatory

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Innate Immunity and Rheumatic Disease - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: In response to pro-inflammatory cytokines released locally during osteoarthritis (OA), such as the alarmins S100A8/A9, monocytes can be recruited from the bone marrow (BM) to the site of injury. Monocyte chemoattractant protein-1 (MCP-1) drives monocyte migration via binding with C-C chemokine receptor type 2 (CCR2). In mice, two functionally distinct monocyte populations are described: pro-inflammatory Ly6C-high monocytes (CCR2high) and patrolling Ly6C-low monocytes (CCR2low). The objectives of our study are to investigate the systemic effects of locally induced OA on BM monocyte populations and their recruitment to the OA joint in collagenase induced OA (CiOA), and the involvement of S100A8/A9 herein.

Methods: CiOA was induced by unilateral-articular collagenase-injection in C57BL/6 mice. At day 7, 21 and 42, mice were sacrificed together with age-matched saline-injected control mice (n=6/group), and expression of several pro-inflammatory cytokines, and MCP-1 and CCR2 were measured in the synovium and serum. During CiOA and control conditions, the absolute amount of cells in the BM of the contralateral femur was measured. Cells from BM, blood and synovial tissue were isolated and analyzed by FACS. Monocyte subsets were identified as (B220/CD90/CD49b/NK1.1/Ly6G)lowCD11bhigh(F4/80/MHCII/CD11c)low and further distinguished by their Ly6C expression. In addition, we investigated the role of S100A8/A9 on monocyte populations during early CiOA using S100A9-/- mice.

Results: Synovial expression of the pro-inflammatory cytokines IL-1β, IL-6, TNF-α, S100A8 and S100A9 were increased at day 7, but only expression of S100A8 and S100A9 remained high until day 21. Local induction of CiOA resulted in systemic effects within the BM as shown by the significant decrease in total cell numbers at day 7 and 21 (both 14%), which decrease is suggested to be Ly6C high monocytes since the absolute amount of these cells decreases. Concurrently, relative number of Ly6C high monocytes and macrophages were significantly increased (764% and 251%, respectively) locally in the synovium at CiOA day 7, corresponding with the increased synovial mRNA expression of MCP-1 (151-fold) and CCR2 (41-fold). Since S100A8/A9 is sustainably expressed during CiOA and intra articular injection of S100A8 leads to significant induction of MCP-1 (8-fold) in the synovium, we next investigated the role of S100A8/A9 during early CiOA in more detail using S100A9-/- mice. S100A9-/- mice show less synovial activation, less cell influx and less cartilage degradation compared to wild type (WT) mice. Interestingly, there was no decrease in cell numbers or Ly6C high monocytes in the BM of S100A9-/- mice. Moreover, in contrast to WT mice, the patrolling Ly6C low monocytes were significantly increased (205%) in S100A9-/- mice, whereas the pro-inflammatory Ly6C high monocytes were not affected.

Conclusion: Local induction of OA induces systemic release of BM-derived Ly6C high monocytes, which are found subsequently increased locally in the synovium, a process that may be regulated by the sustained release of S100A8/A9 from the synovium via MCP-1.


Disclosure: N. Cremers, None; E. Geven, None; A. Blom, None; A. Sloetjes, None; I. Di Ceglie, None; S. van Dalen, None; G. Ascone, None; M. van den Bosch, None; P. van Lent, None.

To cite this abstract in AMA style:

Cremers N, Geven E, Blom A, Sloetjes A, Di Ceglie I, van Dalen S, Ascone G, van den Bosch M, van Lent P. S100A8/A9 Produced during Experimental Osteoarthritis Induces a Systemic Decrease in BM Monocytes and Increases Ly6C High Monocytes Locally in the Joint [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/s100a8a9-produced-during-experimental-osteoarthritis-induces-a-systemic-decrease-in-bm-monocytes-and-increases-ly6c-high-monocytes-locally-in-the-joint/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/s100a8a9-produced-during-experimental-osteoarthritis-induces-a-systemic-decrease-in-bm-monocytes-and-increases-ly6c-high-monocytes-locally-in-the-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology